Literature DB >> 1127579

Rationale for design of biologically reversible drug derivatives: prodrugs.

A A Sinkula, S H Yalkowsky.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1127579     DOI: 10.1002/jps.2600640203

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  25 in total

Review 1.  Targeted prodrug design to optimize drug delivery.

Authors:  H K Han; G L Amidon
Journal:  AAPS PharmSci       Date:  2000

2.  Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma.

Authors:  Wei-hua Ren; Jiang Chang; Cheng-hu Yan; Xiao-min Qian; Li-xia Long; Bin He; Xu-bo Yuan; Chun-sheng Kang; Didier Betbeder; Jing Sheng; Pei-yu Pu
Journal:  J Mater Sci Mater Med       Date:  2010-06-10       Impact factor: 3.896

Review 3.  Prodrugs for the improvement of drug absorption via different routes of administration.

Authors:  L P Balant; E Doelker; P Buri
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 4.  Cyclization-activated prodrugs.

Authors:  Paula Gomes; Nuno Vale; Rui Moreira
Journal:  Molecules       Date:  2007-11-12       Impact factor: 4.411

5.  Sympathomimetic bronchodilators: increased selectivity with lung-specific prodrugs.

Authors:  L A Svensson
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200

Review 6.  Prodrug approaches for CNS delivery.

Authors:  Jarkko Rautio; Krista Laine; Mikko Gynther; Jouko Savolainen
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

7.  Synthesis and biological evaluation of omega-(N,N,N-trialkylammonium)alkyl esters and thioesters of carboxylic acid nonsteroidal antiinflammatory agents.

Authors:  M C Venuti; J M Young; P J Maloney; D Johnson; K McGreevy
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

8.  Selection of a derivative of the antiviral agent 9-[(1,3-dihydroxy-2-propoxy)-methyl]guanine (DHPG) with improved oral absorption.

Authors:  E J Benjamin; B A Firestone; R Bergstrom; M Fass; I Massey; I Tsina; Y Y Lin
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

9.  Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug.

Authors:  K L Amsberry; R T Borchardt
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 10.  Clinical significance of esterases in man.

Authors:  F M Williams
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.